Taylor Frigon Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-9,945
| Closed | -$1.71M | – | 89 |
|
|
2024
Q2 | $1.71M | Sell |
9,945
-470
| -5% | -$77.9K | 0.81% | 56 |
|
|
2024
Q1 | $1.9M | Sell |
10,415
-90
| -0.9% | -$15.5K | 0.9% | 51 |
|
|
2023
Q4 | $1.63M | Sell |
10,505
-372
| -3% | -$54.2K | 0.82% | 51 |
|
|
2023
Q3 | $1.62M | Buy |
10,877
+151
| +1% | +$22.2K | 0.9% | 49 |
|
|
2023
Q2 | $1.45M | Sell |
10,726
-256
| -2% | -$37.5K | 0.71% | 63 |
|
|
2023
Q1 | $1.75M | Sell |
10,982
-366
| -3% | -$56K | 0.96% | 39 |
|
|
2022
Q4 | $1.83M | Sell |
11,348
-1,318
| -10% | -$202K | 1.04% | 35 |
|
|
2022
Q3 | $1.7M | Sell |
12,666
-234
| -2% | -$33.6K | 0.89% | 44 |
|
|
2022
Q2 | $1.98M | Sell |
12,900
-202
| -2% | -$30.9K | 1.03% | 38 |
|
|
2022
Q1 | $2.12M | Sell |
13,102
-293
| -2% | -$42.6K | 0.79% | 49 |
|
|
2021
Q4 | $1.81M | Buy |
13,395
+188
| +1% | +$22.2K | 0.57% | 61 |
|
|
2021
Q3 | $1.43M | Buy |
13,207
+397
| +3% | +$45.4K | 0.46% | 69 |
|
|
2021
Q2 | $1.44M | Buy |
12,810
+839
| +7% | +$94.5K | 0.45% | 61 |
|
|
2021
Q1 | $1.3M | Buy |
11,971
+307
| +3% | +$32.8K | 0.4% | 60 |
|
|
2020
Q4 | $1.25M | Sell |
11,664
-100
| -0.9% | -$9.61K | 0.41% | 61 |
|
|
2020
Q3 | $1.03M | Buy |
11,764
+99
| +0.8% | +$9.32K | 0.45% | 70 |
|
|
2020
Q2 | $1.15M | Buy |
11,665
+24
| +0.2% | +$2.11K | 0.57% | 59 |
|
|
2020
Q1 | $887K | Sell |
11,641
-108
| -0.9% | -$9.2K | 0.7% | 55 |
|
|
2019
Q4 | $1.04M | Sell |
11,749
-216
| -2% | -$17.9K | 0.72% | 60 |
|
|
2019
Q3 | $906K | Buy |
11,965
+215
| +2% | +$14.7K | 0.66% | 75 |
|
|
2019
Q2 | $854K | Buy |
11,750
+81
| +0.7% | +$6.37K | 0.59% | 81 |
|
|
2019
Q1 | $940K | Sell |
11,669
-388
| -3% | -$31.7K | 0.73% | 71 |
|
|
2018
Q4 | $1.11M | Buy |
12,057
+18
| +0.1% | +$1.58K | 0.98% | 47 |
|
|
2018
Q3 | $1.14M | Buy |
12,039
+76
| +0.6% | +$7.21K | 0.86% | 49 |
|
|
2018
Q2 | $1.11M | Sell |
11,963
-1,161
| -9% | -$113K | 0.81% | 52 |
|
|
2018
Q1 | $1.24M | Sell |
13,124
-916
| -7% | -$101K | 0.97% | 46 |
|
|
2017
Q4 | $1.36M | Buy |
+14,040
| New | +$1.32M | 1.09% | 39 |
|
|
2016
Q2 | $847K | Buy |
13,675
+204
| +2% | +$12.4K | 0.88% | 58 |
|
|
2016
Q1 | $769K | Sell |
13,471
-47
| -0.3% | -$2.62K | 0.81% | 59 |
|
|
2015
Q4 | $769K | Buy |
13,518
+196
| +1% | +$11.3K | 0.87% | 56 |
|
|
2015
Q3 | $729K | Buy |
13,322
+553
| +4% | +$36K | 0.81% | 57 |
|
|
2015
Q2 | $869K | Sell |
12,769
-2,934
| -19% | -$192K | 0.9% | 49 |
|
|
2015
Q1 | $913K | Sell |
15,703
-5,021
| -24% | -$303K | 0.84% | 67 |
|
|
2014
Q4 | $1.36M | Buy |
+20,724
| New | +$1.31M | 1.27% | 40 |
|
Other funds holding ABBV
Taylor Frigon Capital Management's ABBV Position: Q3 2024 in Review
Taylor Frigon Capital Management sold out of AbbVie (ABBV) in Q3 2024, closing a stake of 9,945 shares — an estimated $1.71M sold.
Taylor Frigon Capital Management first reported a position in ABBV in Q4 2014 and held it in 34 quarters. The position peaked at $2.12M in Q1 2022. 3,498 funds tracked by Wall St. Rank hold ABBV as of Q3 2024.
- Taylor Frigon Capital Management reported no remaining AbbVie position as of Q3 2024 after selling out during the quarter.
- Taylor Frigon Capital Management sold 9,945 AbbVie shares in Q3 2024, an estimated $1.71M.
- Taylor Frigon Capital Management first reported a position in AbbVie in Q4 2014 and held it in 34 quarters.
- Taylor Frigon Capital Management's AbbVie position peaked at $2.12M in Q1 2022.
- 3,498 funds tracked by Wall St. Rank held AbbVie as of Q3 2024.
Based on Taylor Frigon Capital Management's 13F filing for Q3 2024, filed 23 Oct 2024.